Viewing nowCombinationEnpyang Duo Tablet 5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.

MFDS item code 202201380 · Approved 2022.04.04 · Insurance code 669908410
Improvement of glycemic control in adults with type 2 diabetes
This medication effectively aids blood sugar control in adult patients with type 2 diabetes who are following dietary and exercise regimens, by the combined administration of Empagliflozin and Metformin. It is particularly suitable for patients having difficulty controlling their blood sugar, and caution is advised when used in cases associated with cardiovascular diseases. With proper management, this medication helps improve blood sugar levels and supports health maintenance.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional blood glucose control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; if this happens, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Contraindications, item 2)). Elderly Patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is used to lower blood sugar and is particularly helpful in diabetes treatment. It can cause a rare but fatal side effect known as severe lactic acidosis, thus should not be used in patients with impaired kidney function or certain diseases. Additionally, caution is needed when used alongside insulin or other diabetes medications as hypoglycemic symptoms may occur. Patients with impaired kidney function, acute infections or dehydration, and acute heart conditions should not take this medication as it can pose risks. During treatment with this medication, regular blood tests should be performed to monitor kidney function and blood sugar status, especially for the elderly or those with impaired kidney function. Side effects such as gastrointestinal disturbance, urinary tract infections, genital infections, increased urination, and hypoglycemia may occur; if symptoms are severe, consult a doctor. This medication should be temporarily discontinued before and after surgeries or procedures using radiocontrast agents until kidney function is restored. Pregnant or breastfeeding women should not take this medication, and particularly women who may become pregnant should consult a doctor before use. Alcohol consumption can increase the risk of lactic acidosis, so it is advisable to avoid drinking while on this medication. When administering this medication to the elderly, kidney function should be closely monitored, and dose adjustments made as necessary. In case of overdose, serious issues such as lactic acidosis may occur, so it is important to take the prescribed dose as directed by a doctor. Lastly, keep this medication out of reach of children and store it in its original container to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best kept at room temperatures between 1°C and 30°C, avoiding extremely hot or cold places.
White, oval, double convex film-coated tablet with a yellowish tint
10 tablets/box[(10/PTP X 1)], 60 tablets/box[(10/PTP X 6)], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daehan New Pharm Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.